Delivery Order SPE2DR25D2001-SPE2DR26FBFJ0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,049.61 to AmerisourceBergen Drug Corp for the supply of Ingrezza 60 mg capsules (30-count) under a firm fixed price contract. This non-set-aside award was executed on August 20, 2025, with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,622.18 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units). This firm fixed-price delivery order, awarded on November 7, 2025, with an ultimate completion date of December 2, 2025, represents a non-set-aside competitive procurement. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $4,027.70 by the Defense Logistics Agency on September 8, 2025, for the supply of Ingrezza 80 mg capsules (30-count). This non-set-aside competitive award is scheduled for completion by September 29, 2025, and represents a single transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.69 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on November 5, 2025, with an ultimate completion date of November 28, 2025. This firm fixed-price, non-set-aside contract represents a competitive award for pharmaceutical products supporting federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Ingrezza 80 mg capsules (30-count) with a ceiling value of $4,027.69. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on November 6, 2025, for $4,027.69 to supply Ingrezza 80 mg capsules (30-count units). This is a firm fixed-price contract with a completion date of December 1, 2025, and no set-aside designation was used. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) with a ceiling value of $8,055.40. This firm fixed price delivery order, with an ultimate completion date of October 2, 2025, represents a non-competitive set-aside award and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Ingrezza 60 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,049.61. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBFJ0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,244.58 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on November 12, 2025, with a completion date of December 4, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company maintains a comprehensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Ingrezza, a neurological treatment medication, exemplifies the company's role in fulfilling federal healthcare requirements through competitive procurement mechanisms and demonstrates its capability to support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 11/12/25 |